Differential Immune Effects of Natalizumab

Clinical trial NCT00859482 · COMPLETED

Trial details

NCT number: NCT00859482
Sponsor: Cantonal Hospital of St. Gallen
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis, Relapsing Remitting

Start date: 2006-07-01
Primary completion: 2007-07-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.